Can Deep Tech Startups Propel Drug Discovery – Bio Spectrum

Adding on, entrepreneurs believe that AI has proved to be a boon for startups as it allows them to excel despite smaller teams and smaller fundings. Today, there are many startups worldwide, which focus on one aspect of drug discovery. Some of them are believed to be much faster and more efficient than even the largescale pharmaceutical companies, where multiple layers of approvals are needed for a molecule to move from one stage to another.